Dysbiosis of the intestinal microbiota in neurocritically ill patients and the risk for death
- PMID: 31151471
- PMCID: PMC6544929
- DOI: 10.1186/s13054-019-2488-4
Dysbiosis of the intestinal microbiota in neurocritically ill patients and the risk for death
Abstract
Background: Despite the essential functions of the intestinal microbiota in human physiology, little has been reported about the microbiome in neurocritically ill patients. This investigation aimed to evaluate the characteristics of the gut microbiome in neurocritically ill patients and its changes after admission. Furthermore, we investigated whether the characteristics of the gut microbiome at admission were a risk factor for death within 180 days.
Methods: This prospective observational cohort study included neurocritically ill patients admitted to the neurological intensive care unit of a large university-affiliated academic hospital in Guangzhou. Faecal samples were collected within 72 h after admission (before antibiotic treatment) and serially each week. Healthy volunteers were recruited from a community in Guangzhou. The gut microbiome was monitored via 16S rRNA gene sequence analysis, and the associations with the clinical outcome were evaluated by a Cox proportional hazards model.
Results: In total, 98 patients and 84 age- and sex-matched healthy subjects were included in the analysis. Compared with healthy subjects, the neurocritically ill patients exhibited significantly different compositions of intestinal microbiota. During hospitalization, the α-diversity and abundance of Ruminococcaceae and Lachnospiraceae decreased significantly over time in patients followed longitudinally. The abundance of Enterobacteriaceae was positively associated with the modified Rankin Scale at discharge. In the multivariate Cox regression analysis, Christensenellaceae and Erysipelotrichaceae were associated with an increased risk of death. The increases in intestinal Enterobacteriales and Enterobacteriaceae during the first week in the neurological intensive care unit were associated with increases of 92% in the risk of 180-day mortality after adjustments.
Conclusions: This analysis of the gut microbiome in 98 neurocritically ill patients indicates that the gut microbiota composition in these patients differs significantly from that in a healthy population and that the magnitude of this dysbiosis increases during hospitalization in a neurological intensive care unit. The gut microbiota characteristics seem to have an impact on patients' 180-day mortality. Gut microbiota analysis could hopefully predict outcome in the future.
Keywords: Biomarker; Cohort study; Critical illness; Dysbiosis; Gut microbiome; Prognosis; Stroke.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures




Comment in
-
Dysbiosis of the microbiota in neurocritically ill patients associated with coma and death: ammonia as a potential missing link.Crit Care. 2019 Dec 11;23(1):403. doi: 10.1186/s13054-019-2688-y. Crit Care. 2019. PMID: 31829221 Free PMC article. No abstract available.
Similar articles
-
Marked Changes in Gut Microbiota in Cardio-Surgical Intensive Care Patients: A Longitudinal Cohort Study.Front Cell Infect Microbiol. 2020 Jan 15;9:467. doi: 10.3389/fcimb.2019.00467. eCollection 2019. Front Cell Infect Microbiol. 2020. PMID: 32010644 Free PMC article.
-
Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis.Clin Gastroenterol Hepatol. 2019 Mar;17(4):756-765.e3. doi: 10.1016/j.cgh.2018.07.022. Epub 2018 Jul 20. Clin Gastroenterol Hepatol. 2019. PMID: 30036646
-
Gut microbiota dysbiosis and neurological function recovery after intracerebral hemorrhage: an analysis of clinical samples.Microbiol Spectr. 2024 Nov 5;12(11):e0117824. doi: 10.1128/spectrum.01178-24. Epub 2024 Sep 24. Microbiol Spectr. 2024. PMID: 39315788 Free PMC article.
-
Fecal Microbiota Transplantation for the Critically Ill Patient.Nutr Clin Pract. 2019 Feb;34(1):73-79. doi: 10.1002/ncp.10228. Epub 2018 Dec 18. Nutr Clin Pract. 2019. PMID: 30561131 Review.
-
Gut Microbiome-Based Therapeutics in Critically Ill Adult Patients-A Narrative Review.Nutrients. 2023 Nov 9;15(22):4734. doi: 10.3390/nu15224734. Nutrients. 2023. PMID: 38004128 Free PMC article. Review.
Cited by
-
Human Umbilical Cord Mesenchymal Stem Cells Improve Locomotor Function in Parkinson's Disease Mouse Model Through Regulating Intestinal Microorganisms.Front Cell Dev Biol. 2022 Jan 20;9:808905. doi: 10.3389/fcell.2021.808905. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35127723 Free PMC article.
-
Gut microbiota plays a pivotal role in opioid-induced adverse effects in gastrointestinal system.Crit Care. 2022 Jan 3;26(1):5. doi: 10.1186/s13054-021-03867-0. Crit Care. 2022. PMID: 34980217 Free PMC article. No abstract available.
-
Gut Microbiota and Critically Ill Patients: Immunity and Its Modulation via Probiotics and Immunonutrition.Nutrients. 2023 Aug 13;15(16):3569. doi: 10.3390/nu15163569. Nutrients. 2023. PMID: 37630759 Free PMC article. Review.
-
The human gut microbiome in critical illness: disruptions, consequences, and therapeutic frontiers.J Crit Care. 2024 Feb;79:154436. doi: 10.1016/j.jcrc.2023.154436. Epub 2023 Sep 26. J Crit Care. 2024. PMID: 37769422 Free PMC article. Review.
-
The Mediating Role of Plasma Inflammatory Proteins in Gut Microbiota-Driven Valvular Heart Disease: A Mendelian Randomization Study.Cell Biochem Biophys. 2025 May 28. doi: 10.1007/s12013-025-01780-9. Online ahead of print. Cell Biochem Biophys. 2025. PMID: 40425948
References
-
- Taur Y, Jenq RR, Perales MA, Littmann ER, Morjaria S, Ling L, No D, Gobourne A, Viale A, Dahi PB, et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood. 2014;124(7):1174–1182. doi: 10.1182/blood-2014-02-554725. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- NSFC81671171/National Natural Science Foundation of China
- NSFC81870936/National Natural Science Foundation of China
- 2017A030313821/Guangdong Natural Science Foundation
- LC2016PY025/Clinical Research Startup Program of Southern Medical University by High-level University Construction Funding of Guangdong Provincial Department of Education
LinkOut - more resources
Full Text Sources
Medical